Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN112409137B reveals inorganic base assisted catalysis for high-purity BINOL. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Patent CN104844554B reveals alkali-free synthesis for high-purity Nebivolol intermediates. Enhances supply chain reliability and reduces purification costs significantly.
Patent CN116376872A reveals high-efficiency esterase mutants for (S)-3-cyclohexene-1-carboxylic acid, offering cost reduction and scalable biocatalysis for anticoagulant manufacturing.
Patent CN1438985A details a stereoselective route to gabapentin analogs using chiral enones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel peptide coupling method ensures high purity Nebivolol intermediate with reduced racemization risks for scalable pharmaceutical manufacturing.
Novel DBH inhibitors synthesis via hydrazone cyclization. Cost-effective route for antihypertensive intermediates with high purity specifications.
Patent CN113861066B reveals high-purity synthesis. Offers supply chain stability and cost reduction for pharmaceutical intermediates manufacturing globally.
Patent CN1158244C details a high-purity L-carnitine process from S-chlorosuccinic acid. Discover cost-effective chiral synthesis strategies for pharmaceutical intermediates.
Patent CN110746334A details a 4-step synthesis of 3-(3-chloropropyl)-4-oxopyrrolidine-1-carboxylate, offering high yield and reduced waste for API manufacturing.
Patent CN112939900A reveals a cost-effective route for Brivaracetam intermediates, eliminating chiral chromatography for scalable pharmaceutical manufacturing.
Patent CN102548956B details a novel Stevens rearrangement process for high-purity DTPA derivatives, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel patent CN107987082A details improved Larotrectinib synthesis with lower temperatures and higher purity, offering supply chain stability and cost efficiency for pharmaceutical manufacturers.
Novel metal-free synthesis method for quinoline-2-xanthate. Offers mild conditions, high yield, and supply chain stability for pharmaceutical intermediates.
Patent CN106366089A details heavy-metal-free synthesis for isoindoline derivatives ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturing.
Patent CN111170855A reveals a safer, scalable route for Bempedoic Acid intermediates, offering significant cost reduction in pharmaceutical manufacturing and improved purity profiles.
Novel preparation method for quinone derivatives enhances purity and yield. Ideal for reliable pharmaceutical intermediate supplier seeking cost reduction in API manufacturing.
Patent CN111944016B details a novel solid-phase synthesis using nitro-protection and dipeptide fragments for high-purity icatibant acetate manufacturing.
CN100410266C details a rapid one-step phosphorylation method for etoposide phosphate intermediates, offering significant cost and time reductions for global supply chains.
Patent CN114105872A reveals a stable synthesis for procaterol intermediates, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN104558079B details MeONa deprotection for high-purity Sofosbuvir. Reduces impurities, simplifies process for reliable supply.